• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis
Date Designated:  02/04/2011
Orphan Designation:  Treatment of myasthenia gravis
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
CuraVac Europe SA
Avenue de Villefranche
Rixensart
Belgium

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-